Image
21.07.2021
Six schools in East of England win Diabetes UK award
Six schools across the East of England have won an award for providing great care to children and young p...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more